Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model

OBJECTIVES: In 2010, the 13-valent pneumococcal conjugate vaccine (PCV-13) replaced the 7-valent vaccine (introduced in 2006) for vaccination against invasive pneumococcal diseases (IPDs), pneumonia and acute otitis media (AOM) in the UK. Using recent evidence on the impact of PCVs and epidemiologic...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgleize, Emmanuelle, Leeuwenkamp, Oscar, Theodorou, Eleni, Van de Velde, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168567/
https://www.ncbi.nlm.nih.gov/pubmed/27903558
http://dx.doi.org/10.1136/bmjopen-2015-010776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168567/
https://www.ncbi.nlm.nih.gov/pubmed/27903558
http://dx.doi.org/10.1136/bmjopen-2015-010776

Ejemplares similares